Skip to main content

Eton Pharmaceuticals, Inc. (ETON)

NASDAQ: ETON · IEX Real-Time Price · USD
5.04
+0.03 (0.60%)
After-hours:Sep 24, 2021 7:59 PM EDT
5.01
-0.07 (-1.38%)
At close: Sep 24, 4:00 PM
Market Cap123.25M
Revenue (ttm)16.38M
Net Income (ttm)-11.09M
Shares Out24.60M
EPS (ttm)-0.47
PE Ration/a
Forward PE12.82
Dividendn/a
Ex-Dividend Daten/a
Volume96,742
Open5.06
Previous Close5.08
Day's Range4.99 - 5.10
52-Week Range4.03 - 10.30
Beta1.24
AnalystsBuy
Price Target14.00 (+179.4%)
Est. Earnings DateNov 11, 2021

About ETON

Eton Pharmaceuticals, Inc., a specialty pharmaceutical company, focuses on developing and commercializing pharmaceutical products for rare diseases. The company offers Biorphen, a phenylephrine injection for the treatment of clinically important hypotension resulting primarily from vasodilation in the setting of anesthesia; Alkindi Sprinkle, a replacement therapy for adrenocortical insufficiency in children under 17 years of age; and Alaway Preservative Free, a preservative-free ophthalmic product to treat allergic conjunctivitis. It also devel...

IndustryPharmaceuticals
IPO DateNov 13, 2018
Employees16
Stock ExchangeNASDAQ
Ticker SymbolETON
Full Company Profile

Financial Performance

In 2020, ETON's revenue was $39,000, a decrease of -95.93% compared to the previous year's $959,000. Losses were -$27.97 million, 52.7% more than in 2019.

Financial Statements

Analyst Forecast

According to 2 analysts, the average rating for ETON stock is "Buy." The 12-month stock price forecast is 14.00, which is an increase of 179.44% from the latest price.

Price Target
$14.00
(179.44% upside)
Analyst Consensus: Buy

News

Eton Pharmaceuticals, Inc. (ETON) Reports Q2 Loss, Misses Revenue Estimates

Eton Pharmaceuticals, Inc. (ETON) delivered earnings and revenue surprises of 42.86% and -19.92%, respectively, for the quarter ended June 2021. Do the numbers hold clues to what lies ahead for the stock?

1 month ago - Zacks Investment Research

Eton Pharmaceuticals Reports Second Quarter Financial Results

DEER PARK, Ill., Aug. 16, 2021 (GLOBE NEWSWIRE) -- Eton Pharmaceuticals, Inc (Nasdaq: ETON), an innovative pharmaceutical company focused on developing and commercializing treatments for rare diseases, ...

1 month ago - GlobeNewsWire

Why Is Eton Pharmaceuticals (ETON) Stock Plunging On Monday?

According to an SEC filing, the FDA action date for Eton Pharmaceuticals Inc's (NASDAQ: ETON) antiepileptic topiramate oral solution has been delayed three months to November 6. An FDA decision was expe...

1 month ago - Benzinga

Eton Pharmaceuticals, Inc. (ETON) May Report Negative Earnings: Know the Trend Ahead of Q2 Release

Eton Pharmaceuticals, Inc. (ETON) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

1 month ago - Zacks Investment Research

Eton Pharmaceuticals Buys US, Canadian Rights To Zeneo Hydrocortisone Autoinjector

Eton Pharmaceuticals Inc (NASDAQ: ETON) has acquired the U.S. and Canadian rights to Crossject's Zeneo hydrocortisone needleless autoinjector. The product is under development as a rescue treatment for ...

3 months ago - Benzinga

Eton Pharmaceuticals Acquires U.S. and Canadian Rights to ZENEO® Hydrocortisone Autoinjector

DEER PARK, Ill., June 15, 2021 (GLOBE NEWSWIRE) -- Eton Pharmaceuticals, Inc (Nasdaq: ETON), the U.S. marketer of ALKINDI SPRINKLE®, a treatment for adrenocortical insufficiency in pediatric patients, t...

3 months ago - GlobeNewsWire

Eton Pharma Stock Is Trading Higher After FDA Approval For Rezipres

The FDA has approved Eton Pharmaceuticals Inc's (NASDAQ: ETON) Rezipres (ephedrine hydrochloride injection) to treat clinically significant hypotension occurring in the setting of anesthesia. Rezipres i...

3 months ago - Benzinga

Eton Pharmaceuticals Announces FDA Approval of Rezipres® (Ephedrine Hydrochloride Injection)

DEER PARK, Ill., June 15, 2021 (GLOBE NEWSWIRE) -- Eton Pharmaceuticals, Inc (Nasdaq: ETON) today announced that the U.S. Food and Drug Administration (FDA) has approved Rezipres® (ephedrine hydrochlori...

3 months ago - GlobeNewsWire

Eton Pharmaceuticals, Inc. (ETON) Stock Jumps 5.4%: Will It Continue to Soar?

Eton Pharmaceuticals, Inc. (ETON) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the stock continue moving higher in t...

3 months ago - Zacks Investment Research

Eton Pharmaceuticals Stock Tumbles After FDA Rejects its Dehydrated Alcohol Injection Application For Methanol Poisoning

Eton Pharmaceuticals Inc (NASDAQ: ETON) has received a Complete Response Letter (CRL) from the FDA related to a marketing application for its dehydrated alcohol injection to treat methanol poisoning. Th...

3 months ago - Benzinga

Eton Pharmaceuticals Receives Complete Response Letter from U.S. FDA for Dehydrated Alcohol Injection

DEER PARK, Ill., May 28, 2021 (GLOBE NEWSWIRE) -- Eton Pharmaceuticals, Inc (Nasdaq: ETON), today announced that the company has received a Complete Response Letter (CRL) from the U.S. Food & Drug Admin...

3 months ago - GlobeNewsWire

Do Options Traders Know Something About Eton Pharmaceuticals (ETON) Stock We Don't?

Investors need to pay close attention to Eton Pharmaceuticals (ETON) stock based on the movements in the options market lately.

4 months ago - Zacks Investment Research

Eton Pharmaceuticals, Inc. (ETON) Surges 6.7%: Indication of Further Gains?

Eton Pharmaceuticals, Inc. (ETON) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions may not translate into further p...

4 months ago - Zacks Investment Research

Eton Pharmaceuticals, Inc. (ETON) Q1 Earnings Meet Estimates

Eton Pharmaceuticals, Inc. (ETON) delivered earnings and revenue surprises of 0.00% and -1.29%, respectively, for the quarter ended March 2021. Do the numbers hold clues to what lies ahead for the stock?

4 months ago - Zacks Investment Research

Eton Pharmaceuticals: Q1 Earnings Insights

Shares of Eton Pharmaceuticals (NASDAQ:ETON) moved higher in after-market trading after the company reported Q1 results. Quarterly Results Earnings per share increased 138.00% year over year to $0.19, w...

4 months ago - Benzinga

Eton Pharmaceuticals, Inc. (ETON) Reports Next Week: Wall Street Expects Earnings Growth

Eton Pharmaceuticals, Inc. (ETON) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

4 months ago - Zacks Investment Research

Eton Pharmaceuticals to Report First Quarter 2021 Financial Results on Thursday, May 13, 2021

DEER PARK, Ill., May 04, 2021 (GLOBE NEWSWIRE) -- Eton Pharmaceuticals, Inc (Nasdaq: ETON), an innovative pharmaceutical company focused on developing and commercializing treatments for rare diseases, t...

4 months ago - GlobeNewsWire

Strength Seen in Eton Pharmaceuticals, Inc. (ETON): Can Its 13.1% Jump Turn into More Strength?

Eton Pharmaceuticals, Inc. (ETON) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might help the stock continue moving higher in the n...

5 months ago - Zacks Investment Research

Eton Pharmaceuticals Announces Appointment of Jenn Adams to its Board of Directors

DEER PARK, Ill., March 17, 2021 (GLOBE NEWSWIRE) -- Eton Pharmaceuticals, Inc (Nasdaq: ETON), an innovative pharmaceutical company focused on developing and commercializing treatments for rare diseases,...

6 months ago - GlobeNewsWire

Eton Pharmaceuticals, Inc. (ETON) Reports Q4 Loss, Lags Revenue Estimates

Eton Pharmaceuticals, Inc. (ETON) delivered earnings and revenue surprises of -23.08% and -92.21%, respectively, for the quarter ended December 2020. Do the numbers hold clues to what lies ahead for the...

6 months ago - Zacks Investment Research

Eton Pharmaceuticals Announces Fourth Quarter and Full Year 2020 Financial Results

DEER PARK, Ill., March 16, 2021 (GLOBE NEWSWIRE) -- Eton Pharmaceuticals, Inc (Nasdaq: ETON), an innovative pharmaceutical company focused on developing and commercializing treatments for rare diseases,...

6 months ago - GlobeNewsWire

Analysts Estimate Eton Pharmaceuticals, Inc. (ETON) to Report a Decline in Earnings: What to Look Out for

Eton Pharmaceuticals, Inc. (ETON) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

6 months ago - Zacks Investment Research

Eton Pharmaceuticals to Report Fourth Quarter and Full Year 2020 Financial Results on Tuesday, March 16, 2021

DEER PARK, Ill., March 04, 2021 (GLOBE NEWSWIRE) -- Eton Pharmaceuticals, Inc (Nasdaq: ETON), a specialty pharmaceutical company focused on developing and commercializing innovative treatments for rare ...

6 months ago - GlobeNewsWire

Eton Pharmaceuticals to Participate in 10th Annual SVB Leerink Global Healthcare Conference

DEER PARK, Ill., Feb. 16, 2021 (GLOBE NEWSWIRE) -- Eton Pharmaceuticals, Inc. (Nasdaq: ETON), a specialty pharmaceutical company focused on developing and commercializing innovative treatments for rare ...

7 months ago - GlobeNewsWire